Skip to main content
Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.753
+0.026 (3.51%)
At close: Feb 27, 2026, 4:00 PM EST
0.720
-0.032 (-4.27%)
After-hours: Feb 27, 2026, 7:17 PM EST

Cytosorbents Revenue

Cytosorbents had revenue of $9.49M in the quarter ending September 30, 2025, with 10.12% growth. This brings the company's revenue in the last twelve months to $36.98M, up 23.89% year-over-year. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.

Revenue (ttm)
$36.98M
Revenue Growth
+23.89%
P/S Ratio
1.28
Revenue / Employee
$248,185
Employees
149
Market Cap
47.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202435.59M4.51M14.51%
Dec 31, 202331.08M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TELA Bio 77.06M
electroCore 29.84M
Spectral AI 23.17M
Elutia 21.75M
QT Imaging Holdings 18.93M
NeuroOne Medical Technologies 11.72M
IceCure Medical 2.98M
VolitionRx 1.47M
Revenue Rankings

CTSO News

More News